Publications by authors named "F Lemonnier"

Claim this Profile
P
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).
N Alshatti, F Lemonnier, E Bachy, J Lopez, F Llamas

Immunooncol Technol· March 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.
David Vallois, Edoardo Missiaglia, Luis Veloza, Anja Fischer, Doriane Cavalieri, François Lemonnier

Leukemia· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.
David Vallois, Edoardo Missiaglia, Luis Veloza, Anja Fischer, Doriane Cavalieri, François Lemonnier

Leukemia· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life after second-line Axi-cel in transplant-ineligible patients with large B-cell lymphoma.
Emilie Charton, Amélie Anota, Emmannuel Bachy, Guillaume Cartron, Francois-Xavier Gros, François Lemonnier

Blood Adv· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive fungal infections after CD19 chimeric antigen receptor T-cell therapy for B-cell lymphoma: a Lymphoma study association study from the DESCAR-T (Dispositif d'Enregistrement et Suivi des patients traités par CAR-T cells) registry.
Amélie Bouvier, Amandine Durand, Vivien Dupont, Nicolas Gower, Cristina Castilla Lorente, François Lemonnier

Clin Microbiol Infect· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis